Want to see CCM full AI Analyst Report?
CCM Stock Chart & Stats
$4.80
-$0.04(-0.90%)
At close: 4:00 PM EST
$4.80
-$0.04(-0.90%)
Day’s Range― - ―
52-Week Range$3.18 - $10.77
Previous CloseN/A
Volume954.00
Average Volume (3M)25.64K
Market Cap
$19.06M
Enterprise Value$3.34B
Total Cash (Recent Filing)$177.39M
Total Debt (Recent Filing)$3.82B
Price to Earnings (P/E)―
Beta0.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,815,458
10 Day Avg. Volume72,657
30 Day Avg. Volume25,639
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00853
P/FCF Ratio-0.01
Enterprise Value/Market Cap175.37
Enterprise Value/Revenue9.14
Enterprise Value/Gross Profit-79.87
Enterprise Value/Ebitda-9.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryA 25.9% revenue rebound in 2025 signals recovering demand and better utilization of the company’s clinical platform. Sustained top-line growth improves the odds of leveraging fixed costs, narrowing operating losses over time and reducing relative financing pressure if continued.
Access To External Capital (HK Subsidiary)The HK$68M convertible bond issuance by the Hong Kong subsidiary demonstrates ongoing access to public capital markets and low-cash-cost financing. That structural funding channel provides liquidity optionality for expansion and can ease parent funding needs while preserving near-term cash flow.
Management ContinuityPromoting an experienced internal executive to interim CFO preserves institutional knowledge and execution ability during transition. Continuity in finance leadership supports steadier cash management, capital raising and reporting during strategic reviews, lowering transition execution risk.
Bears Say
Heavy Leverage & Negative EquityA ~3.6 billion debt load coupled with roughly -2.1 billion equity materially constrains financial flexibility. Elevated leverage increases refinancing, covenant and creditor risks, limiting ability to invest or absorb shocks and making the company highly sensitive to cash‑flow variability.
Consistent Cash BurnPersistent negative operating and free cash flows force reliance on external financing to sustain operations. Ongoing cash burn exacerbates leverage issues, raises interest and refinancing burdens, and undermines the company’s capacity to self-fund capex or strategic initiatives absent sustained margin improvement.
Recurring Losses & Volatile MarginsContinued operating and net losses across multiple years with volatile gross profit indicate weak pricing power and/or high cost structure. Without consistent positive operating margins, the firm will struggle to deleverage, invest in growth, or attract lower‑cost capital over the medium term.
Concord Medical Services News
CCM FAQ
What was Concord Medical Services’s price range in the past 12 months?
Concord Medical Services lowest stock price was $3.18 and its highest was $10.77 in the past 12 months.
What is Concord Medical Services’s market cap?
Concord Medical Services’s market cap is $19.06M.
When is Concord Medical Services’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Concord Medical Services’s earnings last quarter?
Currently, no data Available
Is Concord Medical Services overvalued?
According to Wall Street analysts Concord Medical Services’s price is currently Overvalued.
Does Concord Medical Services pay dividends?
Concord Medical Services pays a Notavailable dividend of $0.99 which represents an annual dividend yield of N/A. See more information on Concord Medical Services dividends here
What is Concord Medical Services’s EPS estimate?
Concord Medical Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Concord Medical Services have?
Concord Medical Services has 2,815,458 shares outstanding.
What happened to Concord Medical Services’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Concord Medical Services?
Currently, no hedge funds are holding shares in CCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Technical Analysis
American Shared Hospital Services
―
Joint
―
Cryo-Cell International
―
DocGo
―
P3 Health Partners
―